Zobrazeno 1 - 7
of 7
pro vyhledávání: '"DongSoo Yun"'
Autor:
Byungji, Kim, Ryan R, Hosn, Tanaka, Remba, Dongsoo, Yun, Na, Li, Wuhbet, Abraham, Mariane B, Melo, Manuel, Cortes, Bridget, Li, Yuebao, Zhang, Yizhou, Dong, Darrell J, Irvine
Publikováno v:
Journal of Controlled Release. 353:241-253
The recent clinical success of multiple mRNA-based SARS-CoV-2 vaccines has proven the potential of RNA formulated in lipid nanoparticles (LNPs) in humans, and products based on base-modified RNA, sequence-optimized RNA, and self-replicating RNAs form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a27996f51128028b14f168abfe074d
https://doi.org/10.1016/j.jconrel.2022.11.022
https://doi.org/10.1016/j.jconrel.2022.11.022
Autor:
Ivan S. Pires, Kaiyuan Ni, Mariane Bandeira Melo, Na Li, Elana Ben-Akiva, Laura Maiorino, Jonathan Dye, Kristen A. Rodrigues, DongSoo Yun, Byungji Kim, Ryan R. Hosn, Paula T. Hammond, Darrell J. Irvine
Publikováno v:
Chemical Engineering Journal. 464:142664
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6d015685c497ee626cf851eda18bac05
https://doi.org/10.1016/j.cej.2023.142664
https://doi.org/10.1016/j.cej.2023.142664
Autor:
Neil C. Dalvie, Lisa H. Tostanoski, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, Sakshi Bajoria, Ozan S. Kumru, Amanda J. Martinot, Abishek Chandrashekar, Katherine McMahan, Noe B. Mercado, Jingyou Yu, Aiquan Chang, Victoria M. Giffin, Felix Nampanya, Shivani Patel, Lesley Bowman, Christopher A. Naranjo, Dongsoo Yun, Zach Flinchbaugh, Laurent Pessaint, Renita Brown, Jason Velasco, Elyse Teow, Anthony Cook, Hanne Andersen, Mark G. Lewis, Danielle L. Camp, Judith Maxwell Silverman, Gaurav S. Nagar, Harish D. Rao, Rakesh R. Lothe, Rahul Chandrasekharan, Meghraj P. Rajurkar, Umesh S. Shaligram, Harry Kleanthous, Sangeeta B. Joshi, David B. Volkin, Sumi Biswas, J. Christopher Love, Dan H. Barouch
Publikováno v:
Science advances. 8(11)
Authorized vaccines against SARS-CoV-2 remain less available in low- and middle-income countries due to insufficient supply, high costs, and storage requirements. Global immunity could still benefit from new vaccines using widely available, safe adju
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7367efa4509ffd185820d27cb76c03b2
https://pubmed.ncbi.nlm.nih.gov/35294244
https://pubmed.ncbi.nlm.nih.gov/35294244
Autor:
Charles A. Whittaker, Aiquan Chang, J. Christopher Love, Hanne Leth Andersen, Lisa H. Tostanoski, Ozan S. Kumru, Nicolas Collin, Brooke Fiala, Megan Lok, Neil P. King, Brittany L. Hartwell, Danielle L Camp, Joseph R. Brady, Mary Kate Tracey, Andrew M. Biedermann, Kristen A Rodrigues, Harry Kleanthous, Jing Yang Wang, Katherine McMahan, Judith M. Silverman, Murillo Silva, Sergio A. Rodriguez-Aponte, David B. Volkin, Darrell J. Irvine, Thomas Courant, Maciel Porto, Sangeeta B. Joshi, Jingyou Yu, Patrice M. Dubois, Swagata Kar, Dan H. Barouch, Ashley A. Lemnios, Lauren Carter, Christopher A Naranjo, Ryan S Johnston, Celia Lebas, Dongsoo Yun, Neil C. Dalvie, Carl Walkey, Natalie Brunette, Laura E. Crowell, Kerry R. Love, Kawaljit Kaur, Mark G. Lewis
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs).1 Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access.2 Subunit vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8f708622e17cebfff295c987cf72435
https://doi.org/10.1073/pnas.2106845118
https://doi.org/10.1073/pnas.2106845118
Autor:
Sangeeta B. Joshi, Jingyou Yu, Lisa H. Tostanoski, Christopher A Naranjo, Amanda J. Martinot, J. Christopher Love, Sumi Biswas, Jason Velasco, Judith M. Silverman, Harry Kleanthous, Neil C. Dalvie, Elyse Teow, Kawaljit Kaur, Felix Nampanya, Dongsoo Yun, Sergio A. Rodriguez-Aponte, Shivani A. Patel, David B. Volkin, Sakshi Bajoria, Lesley Bowman, Anthony L. Cook, Mark G. Lewis, Aiquan Chang, Dan H. Barouch, Abishek Chandrashekar, Ozan S. Kumru, Danielle L Camp, Zach Flinchbaugh, Renita Brown, Katherine McMahan, Laurent Pessaint, Hanne Leth Andersen, Noe B. Mercado, Victoria M. Giffin
Publikováno v:
bioRxiv
article-version (status) pre
article-version (number) 1
article-version (status) pre
article-version (number) 1
Vaccines against SARS-CoV-2 have been distributed at massive scale in developed countries, and have been effective at preventing COVID-19. Access to vaccines is limited, however, in low- and middle-income countries (LMICs) due to insufficient supply,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21262442c3432ab8bbd4719f6af0cd74
https://doi.org/10.1101/2021.07.13.452251
https://doi.org/10.1101/2021.07.13.452251
Autor:
Kristen A Rodrigues, Mary Kate Tracey, Andrew M. Biedermann, Harry Kleanthous, Darrell J. Irvine, Judith M. Silverman, Danielle L Camp, Kerry R. Love, Lauren Carter, Thomas Courant, Neil C. Dalvie, Lisa H. Tostanoski, Megan Lok, J. Christopher Love, Nicolas Collin, Katherine McMahan, Swagata Kar, Hanne Leth Andersen, Ashley A. Lemnios, Charles A. Whittaker, Laura E. Crowell, Celia Lebas, Ozan S. Kumru, Joseph R. Brady, Brittany L. Hartwell, Sergio A. Rodriguez-Aponte, Kawaljit Kaur, David B. Volkin, Murillo Silva, Maciel Porto, Patrice M. Dubois, Dan H. Barouch, Neil P. King, Mark G. Lewis, Aiquan Chang, Sangeeta B. Joshi, Jingyou Yu, Christopher A Naranjo, Ryan S Johnston, Dongsoo Yun
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America
Significance Most of the global population resides in low- and middle-income countries, where current vaccines for COVID-19 remain largely unavailable. For the COVID-19 pandemic, the world will need access to >10 billion doses of vaccines, or more th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6373cc0f780250cecb0fb11b4efe5894
https://pubmed.ncbi.nlm.nih.gov/34493582
https://pubmed.ncbi.nlm.nih.gov/34493582
Autor:
Apolonia Gardner, Johanna L’Heureux, Rosanna M. Zhang, Dominique Leboeuf, Elena M. Smekalova, Jaimie Rogner, Jee Won Yang, Joy Collins, Dongsoo Yun, Ruonan Cao, Christian K. Soule, Natsuda Navamajiti, Siddartha Tamang, Keiko Ishida, Aaron Lopes, Jaime H. Cheah, Paul Chamberlain, Robert Langer, Giovanni Traverso, Kaitlyn Hess, Ameya R. Kirtane, Yulia Rybakova, Abigail K. R. Lytton-Jean, Alison Hayward, Thomas von Erlach, Daniel Reker, Tina Esfandiary
Publikováno v:
Nature nanotechnology
Nanoformulations are transforming our capacity to effectively deliver and treat a myriad of conditions. However, many nanoformulation approaches still suffer from high production complexity and low drug loading. One potential solution relies on harne
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21fe1f143b641e134ff5bbb444226114
https://doi.org/10.1101/786251
https://doi.org/10.1101/786251